Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0046486 | glycerolipid metabolic process | 96/3159 | 414/18670 | 0.0005772 | 0.01653 | 0.01376 | 96 | RABC89 | |
BP | GO:0022612 | gland morphogenesis | 35/3159 | 120/18670 | 0.0005851 | 0.01668 | 0.01389 | 35 | RABC89 | |
BP | GO:0014032 | neural crest cell development | 26/3159 | 81/18670 | 0.0005959 | 0.01691 | 0.01408 | 26 | RABC89 | |
BP | GO:0032635 | interleukin-6 production | 44/3159 | 161/18670 | 0.0005992 | 0.01692 | 0.01409 | 44 | RABC89 | |
BP | GO:0002695 | negative regulation of leukocyte activation | 47/3159 | 175/18670 | 0.0006063 | 0.01694 | 0.01411 | 47 | RABC89 | |
BP | GO:0046165 | alcohol biosynthetic process | 47/3159 | 175/18670 | 0.0006063 | 0.01694 | 0.01411 | 47 | RABC89 | |
BP | GO:0044282 | small molecule catabolic process | 102/3159 | 445/18670 | 0.0006078 | 0.01694 | 0.01411 | 102 | RABC89 | |
BP | GO:0032675 | regulation of interleukin-6 production | 42/3159 | 152/18670 | 0.0006171 | 0.01712 | 0.01426 | 42 | RABC89 | |
BP | GO:0030879 | mammary gland development | 40/3159 | 143/18670 | 0.0006306 | 0.01736 | 0.01446 | 40 | RABC89 | |
BP | GO:0006661 | phosphatidylinositol biosynthetic process | 34/3159 | 116/18670 | 0.0006312 | 0.01736 | 0.01446 | 34 | RABC89 | |
BP | GO:0006766 | vitamin metabolic process | 38/3159 | 134/18670 | 0.0006384 | 0.01749 | 0.01456 | 38 | RABC89 | |
BP | GO:0032535 | regulation of cellular component size | 87/3159 | 370/18670 | 0.0006446 | 0.01758 | 0.01464 | 87 | RABC89 | |
BP | GO:0006801 | superoxide metabolic process | 24/3159 | 73/18670 | 0.0006475 | 0.01758 | 0.01464 | 24 | RABC89 | |
BP | GO:0035107 | appendage morphogenesis | 41/3159 | 148/18670 | 0.0006725 | 0.01803 | 0.01501 | 41 | RABC89 | |
BP | GO:0035108 | limb morphogenesis | 41/3159 | 148/18670 | 0.0006725 | 0.01803 | 0.01501 | 41 | RABC89 | |
BP | GO:0035148 | tube formation | 41/3159 | 148/18670 | 0.0006725 | 0.01803 | 0.01501 | 41 | RABC89 | |
BP | GO:0070203 | regulation of establishment of protein localization to telomere | 7/3159 | 11/18670 | 0.0006893 | 0.01814 | 0.01511 | 7 | RABC89 | |
BP | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 18/3159 | 49/18670 | 0.00069 | 0.01814 | 0.01511 | 18 | RABC89 | |
BP | GO:0008154 | actin polymerization or depolymerization | 54/3159 | 209/18670 | 0.000691 | 0.01814 | 0.01511 | 54 | RABC89 | |
BP | GO:0042446 | hormone biosynthetic process | 27/3159 | 86/18670 | 0.000696 | 0.01814 | 0.01511 | 27 | RABC89 | |
BP | GO:0048013 | ephrin receptor signaling pathway | 27/3159 | 86/18670 | 0.000696 | 0.01814 | 0.01511 | 27 | RABC89 | |
BP | GO:0016266 | O-glycan processing | 21/3159 | 61/18670 | 0.0006996 | 0.01814 | 0.01511 | 21 | RABC89 | |
BP | GO:0030888 | regulation of B cell proliferation | 21/3159 | 61/18670 | 0.0006996 | 0.01814 | 0.01511 | 21 | RABC89 | |
BP | GO:0045604 | regulation of epidermal cell differentiation | 21/3159 | 61/18670 | 0.0006996 | 0.01814 | 0.01511 | 21 | RABC89 | |
BP | GO:0006590 | thyroid hormone generation | 9/3159 | 17/18670 | 0.0007394 | 0.01909 | 0.0159 | 9 | RABC89 | |
BP | GO:0048706 | embryonic skeletal system development | 36/3159 | 126/18670 | 0.0007513 | 0.01922 | 0.016 | 36 | RABC89 | |
BP | GO:0045064 | T-helper 2 cell differentiation | 8/3159 | 14/18670 | 0.0007593 | 0.01922 | 0.016 | 8 | RABC89 | |
BP | GO:0045605 | negative regulation of epidermal cell differentiation | 8/3159 | 14/18670 | 0.0007593 | 0.01922 | 0.016 | 8 | RABC89 | |
BP | GO:0071361 | cellular response to ethanol | 8/3159 | 14/18670 | 0.0007593 | 0.01922 | 0.016 | 8 | RABC89 | |
BP | GO:2001044 | regulation of integrin-mediated signaling pathway | 8/3159 | 14/18670 | 0.0007593 | 0.01922 | 0.016 | 8 | RABC89 |